Serum Institute seeks DCGI approval for phase 3 trial of Covovax as booster dose MD Bureau28 Feb 2022 12:35 PM ISTCovovax is approved by the European Medicines Agency for conditional marketing authorisation and also granted emergency use listing by WHO.
Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Moderna says COVID entering endemic phase, but annual vaccines will be needed MD Bureau28 Feb 2022 10:00 AM ISTBurton warned people will still get sick and die from Covid even when the virus becomes endemic.
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Coronavirus vaccine sales push Moderna to USD 12 billion profit in 2021 MD Bureau26 Feb 2022 3:47 PM ISTWashington: Moderna's COVID-19 vaccine brought in nearly USD 7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase...
New study raises suspicion of coronavirus being developed in lab MD Bureau26 Feb 2022 12:19 PM ISTThe scientist team, including Akhil Varshney from Dr Shroff Charity Eye Hospital in New Delhi, showed a tiny snippet of a genetic material owned by...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
GSK, Sanofi to seek regulatory authorization for COVID vaccine MD Bureau24 Feb 2022 11:00 AM ISTParis: Sanofi and GSK have announced that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory...
Pfizer COVID vaccine approved in South Korea for 5-11 years old MD Bureau24 Feb 2022 10:00 AM ISTThe vaccine will help protect younger children from infections or serious illness amid South Korea's fast-developing omicron surge, the MDFS added.
Very small blood clot risk after first AstraZeneca COVID dose, suggests Study MD Bureau24 Feb 2022 9:00 AM ISTStudy found no risk of major arterial and venous thrombotic events in those aged 70 or above with either of the vaccines.
Experts warn of Omicron subvariant BA.2 Roshni Dhar23 Feb 2022 4:29 PM ISTThe omicron subvariant, BA.2, appeared to be "steadily increasing" in prevalence and that BA.2 had now become dominant in several Asian countries,...
Corbevax gets DCGI emergency use nod for 12-18 age group Roshni Dhar23 Feb 2022 4:12 PM ISTBiological E. Limited has announced that its CORBEVAX vaccine, which is India's first indigenously developed Receptor Binding Domain (RBD) Protein...
